Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cosmos Health Inc. - Common Stock
(NQ:
COSM
)
0.6200
+0.0400 (+6.90%)
Streaming Delayed Price
Updated: 10:14 AM EST, Dec 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
78,842
Open
0.6000
Bid (Size)
0.6110 (10)
Ask (Size)
0.6460 (6)
Prev. Close
0.5800
Today's Range
0.6000 - 0.6891
52wk Range
0.4677 - 1.650
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000
Today 9:25 EST
Via
ACCESSWIRE
Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price
November 26, 2024
Via
ACCESSWIRE
Performance
YTD
-54.74%
-54.74%
1 Month
-16.67%
-16.67%
3 Month
-38.61%
-38.61%
6 Month
-4.62%
-4.62%
1 Year
-55.40%
-55.40%
More News
Read More
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets
November 18, 2024
Via
ACCESSWIRE
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M QoQ
November 14, 2024
Via
ACCESSWIRE
Cosmos Health Issues Letter to Shareholders
November 12, 2024
Via
ACCESSWIRE
Why Cosmos Health Stock Is Moving Higher Wednesday
August 21, 2024
Via
Benzinga
COSM Stock Earnings: Cosmos Health Reported Results for Q2 2024
August 20, 2024
Via
InvestorPlace
Cosmos Health’s Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%
November 01, 2024
Via
ACCESSWIRE
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit
October 01, 2024
Via
News Direct
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands
September 25, 2024
Via
ACCESSWIRE
Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins
September 23, 2024
Via
ACCESSWIRE
Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits
September 23, 2024
Via
ACCESSWIRE
Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion
September 19, 2024
Via
ACCESSWIRE
Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments
September 18, 2024
Via
ACCESSWIRE
Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price
September 17, 2024
Via
ACCESSWIRE
Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar
September 16, 2024
Via
ACCESSWIRE
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
August 28, 2024
Via
Benzinga
Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements
August 23, 2024
Via
ACCESSWIRE
Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE
August 21, 2024
Via
ACCESSWIRE
Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits
August 21, 2024
Via
ACCESSWIRE
Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023
August 20, 2024
Via
ACCESSWIRE
Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit
August 20, 2024
Via
ACCESSWIRE
Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market
August 08, 2024
Via
ACCESSWIRE
Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share
August 06, 2024
Via
ACCESSWIRE
Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar
July 25, 2024
Via
ACCESSWIRE
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.